These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 30677745)

  • 21. Neonatal Opioid Withdrawal Syndrome.
    Patrick SW; Barfield WD; Poindexter BB;
    Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33106341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between punitive policies and neonatal abstinence syndrome among Medicaid-insured infants in complex policy environments.
    Faherty LJ; Heins S; Kranz AM; Patrick SW; Stein BD
    Addiction; 2022 Jan; 117(1):162-171. PubMed ID: 34096671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Women, Infants, and Opioids.
    Lowe NK
    J Obstet Gynecol Neonatal Nurs; 2017; 46(5):657-659. PubMed ID: 28802558
    [No Abstract]   [Full Text] [Related]  

  • 24. Association of Criminal Statutes for Opioid Use Disorder With Prevalence and Treatment Among Pregnant Women With Commercial Insurance in the United States.
    Gressler LE; Shah S; Shaya FT
    JAMA Netw Open; 2019 Mar; 2(3):e190338. PubMed ID: 30848807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study.
    McQueen KA; Murphy-Oikonen J; Desaulniers L
    Matern Child Health J; 2015 Aug; 19(8):1756-65. PubMed ID: 25656717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maternal opioid use disorder and infant mortality in Wisconsin, United States, 2010-2018.
    Mallinson DC; Kuo HD; Kirby RS; Wang Y; Berger LM; Ehrenthal DB
    Prev Med; 2024 Apr; 181():107914. PubMed ID: 38408650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infants Born to Opioid-Dependent Women in Ontario, 2002-2014.
    Brogly SB; Turner S; Lajkosz K; Davies G; Newman A; Johnson A; Dow K
    J Obstet Gynaecol Can; 2017 Mar; 39(3):157-165. PubMed ID: 28343557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contraceptive initiation after delivery among women with and without opioid use disorders: A retrospective cohort study in a statewide Medicaid population, 2005-2016.
    Charron E; Rennert L; Mayo RM; Eichelberger KY; Dickes L; Truong KD
    Drug Alcohol Depend; 2021 Mar; 220():108533. PubMed ID: 33513446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal Substance Exposure and Neonatal Abstinence Syndrome: State Estimates from the 2016-2020 Transformed Medicaid Statistical Information System.
    West KD; Ali MM; Blanco M; Natzke B; Nguyen L
    Matern Child Health J; 2023 Dec; 27(Suppl 1):14-22. PubMed ID: 37219692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medications for opioid use disorder among pregnant women referred by criminal justice agencies before and after Medicaid expansion: A retrospective study of admissions to treatment centers in the United States.
    Winkelman TNA; Ford BR; Shlafer RJ; McWilliams A; Admon LK; Patrick SW
    PLoS Med; 2020 May; 17(5):e1003119. PubMed ID: 32421717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Within-Hospital Concordance of Opioid Exposure Diagnosis Coding in Mothers and Newborns.
    Clark RRS; French R; Lorch S; O'Rourke K; Rosenbaum KEF; Lake ET
    Hosp Pediatr; 2021 Aug; 11(8):825-833. PubMed ID: 34230061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conceptualizing Neonatal Abstinence Syndrome as a Cascade of Care: A Qualitative Study With Healthcare Providers in Ohio.
    Syvertsen JL; Toneff H; Madden DR; Clapp JD
    Adv Neonatal Care; 2018 Dec; 18(6):488-499. PubMed ID: 30234507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder.
    Smart R; Kim JY; Kennedy S; Tang L; Allen L; Crane D; Mack A; Mohamoud S; Pauly N; Perez R; Donohue J
    J Subst Abuse Treat; 2023 Jan; 144():108921. PubMed ID: 36327615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal Abstinence Syndrome: Trend and Expenditure in Louisiana Medicaid, 2003-2013.
    Okoroh EM; Gee RE; Jiang B; McNeil MB; Hardy-Decuir BA; Zapata AL
    Matern Child Health J; 2017 Jul; 21(7):1479-1487. PubMed ID: 28168591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Practical Approach to Neonatal Opiate Withdrawal Syndrome.
    Devlin LA; Davis JM
    Am J Perinatol; 2018 Mar; 35(4):324-330. PubMed ID: 29100261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid Exposed Mothers and Infants in Delaware: Clinical and Legal Considerations.
    Savin MK; Paul DA
    Del Med J; 2016 Apr; 88(4):110-4. PubMed ID: 27263243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal opioid use as a predictor of postpartum suicide attempts among reproductive-age women enrolled in Oregon Medicaid.
    Yoon J; Masoumirad M; Bui LN; Richard P; Harvey SM
    BMC Womens Health; 2024 Mar; 24(1):196. PubMed ID: 38528563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnancy and the Opioid Epidemic.
    Haycraft AL
    J Psychosoc Nurs Ment Health Serv; 2018 Mar; 56(3):19-23. PubMed ID: 29505087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017.
    Hirai AH; Ko JY; Owens PL; Stocks C; Patrick SW
    JAMA; 2021 Jan; 325(2):146-155. PubMed ID: 33433576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal opioid use disorder at delivery hospitalization in a rural state: Maine, 2009-2018.
    Gabrielson SMB; Carwile JL; O'Connor AB; Ahrens KA
    Public Health; 2020 Apr; 181():171-179. PubMed ID: 32065884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.